BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28031702)

  • 1. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting.
    Choi JS; Park JS
    Drug Des Devel Ther; 2017; 11():17-26. PubMed ID: 28031702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
    Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
    Jiang S; Gong X; Zhao X; Zu Y
    Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
    Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
    J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
    Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
    Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
    Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer.
    Liang Z; Yang N; Jiang Y; Hou C; Zheng J; Shi J; Zhang R; Li D; Liu Y; Zuo P
    Int J Pharm; 2015 Oct; 494(1):337-45. PubMed ID: 26299762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
    Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.
    Zu Y; Hu Y; Yu X; Jiang S
    Anticancer Agents Med Chem; 2017; 17(4):542-551. PubMed ID: 27539313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
    Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
    Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
    Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
    Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
    Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
    J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
    Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
    J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p-Aminophenyl-α-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain.
    Singh I; Swami R; Jeengar MK; Khan W; Sistla R
    Chem Phys Lipids; 2015 May; 188():1-9. PubMed ID: 25819559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of surface curcumin nanoparticles modified with biological macromolecules for anti-tumor effects.
    Choi JS
    Int J Biol Macromol; 2016 Nov; 92():850-859. PubMed ID: 27481341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.